These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31077601)

  • 1. Alteplase Therapy for Acute Ischemic Stroke in Pregnancy: Two Case Reports and a Systematic Review of the Literature.
    Ryman KM; Pace WD; Smith S; Fontaine GV
    Pharmacotherapy; 2019 Jul; 39(7):767-774. PubMed ID: 31077601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
    Demaerschalk BM; Kleindorfer DO; Adeoye OM; Demchuk AM; Fugate JE; Grotta JC; Khalessi AA; Levy EI; Palesch YY; Prabhakaran S; Saposnik G; Saver JL; Smith EE;
    Stroke; 2016 Feb; 47(2):581-641. PubMed ID: 26696642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature.
    Tversky S; Libman RB; Reppucci ML; Tufano AM; Katz JM
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e167-70. PubMed ID: 27523596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
    Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data.
    Bluhmki E; Danays T; Biegert G; Hacke W; Lees KR
    Stroke; 2020 Aug; 51(8):2322-2331. PubMed ID: 32611284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.
    Hill MD; Barber PA; Demchuk AM; Newcommon NJ; Cole-Haskayne A; Ryckborst K; Sopher L; Button A; Hu W; Hudon ME; Morrish W; Frayne R; Sevick RJ; Buchan AM
    Stroke; 2002 Jan; 33(1):279-82. PubMed ID: 11779923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.
    Otwell JL; Phillippe HM; Dixon KS
    Am J Health Syst Pharm; 2010 Jul; 67(13):1070-4. PubMed ID: 20554592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
    CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of alteplase in the treatment of acute ischemic stroke.
    Micieli G; Marcheselli S; Tosi PA
    Vasc Health Risk Manag; 2009; 5(1):397-409. PubMed ID: 19475777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic Therapy of Acute Ischemic Stroke during Early Pregnancy.
    Landais A; Chaumont H; Dellis R
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e20-e23. PubMed ID: 29191741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteplase in acute ischemic stroke: putting the guidelines into practice.
    Nagaraja N; Adams HP
    CNS Drugs; 2014 Nov; 28(11):1035-45. PubMed ID: 25326784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
    Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM
    Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the Updated Food and Drug Administration Alteplase Label for Acute Ischemic Stroke: The Estimated Impact and Current Guidelines.
    Shiue HJ; Albright KC; Sands KA
    Ann Pharmacother; 2018 Apr; 52(4):388-391. PubMed ID: 29302990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study.
    Amlie-Lefond C; deVeber G; Chan AK; Benedict S; Bernard T; Carpenter J; Dowling MM; Fullerton H; Hovinga C; Kirton A; Lo W; Zamel K; Ichord R;
    Lancet Neurol; 2009 Jun; 8(6):530-6. PubMed ID: 19423401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of standard-dose (.9-mg/kg) alteplase intravenous thrombolysis for acute ischemic stroke in Afro-Caribbeans, French West Indies.
    Chausson N; Olindo S; Joux J; Saint-Vil M; Aveillan M; Smadja D
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1776-80. PubMed ID: 24957315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.